Such prevalence is consistent with other tumours such as AML and colorectal and pancreatic cancer (Fig. 2), but other malignancies, such as breast cancer and multiple myeloma, show considerably less, suggesting that association between mutated TP53 and del17p may be cancer dependent. Here, TP53 is linked to breast cancer.